The Chicago Entrepreneur

GSK ups 2024 guidance as HIV drugs and new vaccines boost its bottom line

The British drugmaker’s remaining 4.2% stake in its consumer health arm Haleon also boosted its bottom line, following its spin off in July 2022

Previous post The incredible homes of Taylor Swift’s ex-boyfriends (or tortured poets?)
Next post Treasury yields hold near 2024 highs as traders eye Fed decision